{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:25:21Z","timestamp":1783049121268,"version":"3.54.6"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":309,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["486760\/2013-0"],"award-info":[{"award-number":["486760\/2013-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2012\/12247-8"],"award-info":[{"award-number":["2012\/12247-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/07367-5"],"award-info":[{"award-number":["2016\/07367-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.cbi.2019.108888","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T16:47:10Z","timestamp":1572713230000},"page":"108888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["AMPK activation induced by promethazine increases NOXA expression and Beclin-1 phosphorylation and drives autophagy-associated apoptosis in chronic myeloid leukemia"],"prefix":"10.1016","volume":"315","author":[{"given":"Hyllana C.D.","family":"Medeiros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Colturato-Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia S.","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia A.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian W.R.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar Julian","family":"Paredes-Gamero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivarne L.S.","family":"Tersariol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2019.108888_bib1","series-title":"Latest Global Cancer Data","author":"World Health Organization [internet]","year":"2018"},{"key":"10.1016\/j.cbi.2019.108888_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.etap.2017.08.014","article-title":"Long non-coding RNAs: the novel diagnostic biomarkers for leukemia","volume":"55","author":"Chen","year":"2017","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108888_bib3","author":"Global Cancer Observatory [internet]"},{"key":"10.1016\/j.cbi.2019.108888_bib4","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/ajh.23728","article-title":"Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: minimum 24\u2010month follow\u2010up","volume":"89","author":"Gambacorti-Passerini","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cbi.2019.108888_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.blre.2014.06.001","article-title":"Practical issues surrounding the explosion of tyrosine kinase inhibitors for the management of chronic myeloid leukemia","volume":"28","author":"Mathisen","year":"2014","journal-title":"Blood Rev."},{"key":"10.1016\/j.cbi.2019.108888_bib6","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.18632\/oncotarget.6742","article-title":"FZD7 regulates BMSC-mediated protection of CML cells","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2019.108888_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3389\/fonc.2017.00273","article-title":"Giving drugs a second chance: overcoming regulatory and financial hurdles in repurposing approved drugs as cancer therapeutics","volume":"7","author":"Hernandez","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cbi.2019.108888_bib8","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.2174\/1568026616666160216155556","article-title":"Repurposing of old drugs towards new cancer drug discovery","volume":"16","author":"Chen","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.cbi.2019.108888_bib9","first-page":"683","article-title":"Metformin and cancer: an existing drug for cancer prevention and therapy","volume":"15","author":"Fuming","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cbi.2019.108888_bib10","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.bcp.2010.06.052","article-title":"On the mechanisms of phenothiazine-induced mitochondrial permeability transition: thiol oxidation, strict Ca2+dependence, and cyt c release","volume":"80","author":"Cruz","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108888_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tox.2015.02.004","article-title":"Cytotoxicity of phenothiazine derivatives associated with mitochondrial dysfunction: a structure-activity investigation","volume":"1","author":"De Faria","year":"2015","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2019.108888_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/JMN:22:3:189","article-title":"Characterization of phenothiazine-induced apoptosis in neuroblastoma and glioma cell lines: clinical relevance and possible application for brain-derived tumors","volume":"22","author":"Gil-Ad","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.cbi.2019.108888_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00280-003-0738-1","article-title":"Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes","volume":"53","author":"Zhelev","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108888_bib14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1172\/JCI65093","article-title":"Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia","volume":"124","author":"Gutierrez","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cbi.2019.108888_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.phrs.2016.05.032","article-title":"Enhancement of chlorpromazine antitumor activity by Pluronics F127\/L81 nanostructured system against human multidrug resistant leukemia","volume":"111","author":"Mello","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2019.108888_bib16","series-title":"Goodman and Gilman's. The Pharmacological Basis of Therapeutics. 11th McGraw-Hill; New York","article-title":"Drugs and the treatment of psychiatric disorders. Chapters 17 and 18","author":"Baldessarini","year":"2005"},{"key":"10.1016\/j.cbi.2019.108888_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1042\/bj1060155","article-title":"The inhibitory effects in vitro of phenothiazines and other drugs on lipid-peroxidation systems in rat liver microsomes, and their relationship to the liver necrosis produced by carbon tetrachloride","volume":"106","author":"Slater","year":"1968","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2019.108888_bib18","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1399-6576.1995.tb04210.x","article-title":"Premedication with promethazine and transdermal scopolamine reduces the incidence of nausea and vomiting after intrathecal morphine","volume":"39","author":"Tarkkila","year":"1995","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.cbi.2019.108888_bib19","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1038\/s41598-017-06752-5","article-title":"Phenothiazines enhance mild hypothermia-induced neuroprotection via PI3K\/Akt regulation in experimental stroke","volume":"7","author":"An","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2019.108888_bib20","doi-asserted-by":"crossref","first-page":"8140","DOI":"10.1007\/s12035-016-0280-x","article-title":"Neuroprotection by chlorpromazine and promethazine in severe transient and permanent ischemic stroke","volume":"54","author":"Geng","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cbi.2019.108888_bib21","doi-asserted-by":"crossref","first-page":"9153","DOI":"10.1074\/jbc.M112.440354","article-title":"Reversing the Warburg effect as a treatment for glioblastoma","volume":"288","author":"Poteet","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2019.108888_bib22","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/030089169007600314","article-title":"Prevention of cisplatin-induced vomiting in patients with cancer. A pilot study with a multiagent protocol","volume":"76","author":"Federico","year":"1990","journal-title":"Tumori"},{"key":"10.1016\/j.cbi.2019.108888_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.190","article-title":"Organopalladium compound 7b targets mitochondrial thiols and induces caspase-dependent apoptosis in human myeloid leukemia cells","author":"Moraes","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2019.108888_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2019.108888_bib25","first-page":"9","article-title":"Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematological malignancies","volume":"34","author":"Reed","year":"1997","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.cbi.2019.108888_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molcel.2011.02.009","article-title":"Oncogenic ras-induced expression of noxa and beclin-1 promotes autophagic cell death and limits clonogenic survival","volume":"42","author":"Elgendy","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cbi.2019.108888_bib27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1042\/bj2720577","article-title":"Both endocytic and endogenous protein degradation in fibroblasts is stimulated by serum\/amino acid deprivation and inhibited by 3-methyladenine","volume":"272","author":"Hendil","year":"1990","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2019.108888_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1042\/BST0350245","article-title":"Chemically targeting the PI3 K family","volume":"35","author":"Knight","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.cbi.2019.108888_bib29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4161\/auto.1.2.1697","article-title":"Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy","volume":"1","author":"Tanida","year":"2005","journal-title":"Autophagy"},{"key":"10.1016\/j.cbi.2019.108888_bib30","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.febslet.2010.01.017","article-title":"mTOR regulation of autophagy","volume":"584","author":"Jung","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cbi.2019.108888_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cbi.2019.108888_bib32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","article-title":"Methods in mammalian autophagy research","volume":"140","author":"Mizushima","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2019.108888_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4161\/auto.7.3.14487","article-title":"Selective autophagy mediated by autophagic adapter proteins","volume":"7","author":"Johansen","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.cbi.2019.108888_bib34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-018-0624-2","article-title":"Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy","volume":"11","author":"Rossari","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cbi.2019.108888_bib35","article-title":"Inhibition of c-Myc overcomes cytotoxic drug resistance in acute myeloid leukemia cells by promoting differentiation","volume":"9","author":"Pan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2019.108888_bib36","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.18632\/oncotarget.2353","article-title":"Selective JAK2\/ABL dual inhibition therapy effectively eliminates TKI-insensitive CML stem\/progenitor cells","volume":"18","author":"Lin","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2019.108888_bib37","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nm.4336","article-title":"Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia","volume":"23","author":"Giustacchini","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2019.108888_bib38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2017.07.013","article-title":"Drug repurposing in cancer","volume":"124","author":"Sleire","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2019.108888_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-0944-5_1","article-title":"Pharmacological inhibitors of exocytosis and endocytosis: novel bullets for old targets","volume":"1174","author":"Ivanov","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cbi.2019.108888_bib40","doi-asserted-by":"crossref","first-page":"27540","DOI":"10.1038\/srep27540","article-title":"Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents: a drug repurposing strategy","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2019.108888_bib41","first-page":"28","article-title":"Phenothiazines and related drugs as multi drug resistance reversal agents in cancer chemotherapy mediated by P-glycoprotein","volume":"13","author":"Ravinesh","year":"2017","journal-title":"Curr. Cancer Ther. Rev."},{"key":"10.1016\/j.cbi.2019.108888_bib42","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000124","article-title":"Abuse and intentional misuse of promethazine reported to US poison centers: 2002 to 2012","volume":"9","author":"Tsay","year":"2015","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.cbi.2019.108888_bib43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/15563650.2016.1164861","article-title":"Antipsychotic-related fatal poisoning, England and Wales, 1993\u22122013: impact of the withdrawal of thioridazine","volume":"54","author":"Handley","year":"2016","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.cbi.2019.108888_bib44","first-page":"823","article-title":"Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells. Cancer Chemother","volume":"67","author":"D\u00f6nmez","year":"2011","journal-title":"Pharmacol."},{"key":"10.1016\/j.cbi.2019.108888_bib45","doi-asserted-by":"crossref","DOI":"10.3791\/2597","article-title":"Modified annexin V\/propidium iodide apoptosis assay for accurate assessment of cell death","author":"Rieger","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.cbi.2019.108888_bib46","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/ncb3236","article-title":"An interconnected hierarchical model of cell death regulation by the BCL-2 family","volume":"17","author":"Chen","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cbi.2019.108888_bib47","doi-asserted-by":"crossref","first-page":"17208","DOI":"10.1074\/jbc.RA118.002579","article-title":"Mitochondria-derived ROS activate AMP-activated protein kinase (AMPK) indirectly","volume":"293","author":"Hinchy","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2019.108888_bib48","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/blood-2004-08-3225","article-title":"Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia","volume":"106","author":"Sujobert","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2019.108888_bib49","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/aps.2016.121","article-title":"The PI3K\/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia","volume":"38","author":"Deng","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cbi.2019.108888_bib50","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.biopha.2018.04.089","article-title":"In vitro anti-leukemia activity of dual PI3K\/mTOR inhibitor Voxtalisib on HL60 and K562 cells, as well as their multidrug resistance counterparts HL60\/ADR and K562\/A02 cells","volume":"103","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2019.108888_bib51","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1159\/000490142","article-title":"The critical role of PTEN\/PI3K\/AKT signaling pathway in shikonin-induced apoptosis and proliferation inhibition of chronic myeloid leukemia","volume":"47","author":"Chen","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.cbi.2019.108888_bib52","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/15548627.2018.1564557","article-title":"Structural insights into BCL2 pro-survival protein interactions with the key autophagy regulator BECN1 following phosphorylation by STK4\/MST1","volume":"15","author":"Lee","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.cbi.2019.108888_bib53","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1093\/hmg\/ddp327","article-title":"Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair","volume":"18","author":"Rothfuss","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cbi.2019.108888_bib54","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.bbamcr.2009.03.002","volume":"1793","author":"Tolkovsky","year":"2009","journal-title":"Mitophagy. Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2019.108888_bib55","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/jnc.13412","article-title":"Mitochondrial and lysosomal biogenesis are activated following PINK1\/parkin-mediated mitophagy","volume":"136","author":"Ivankovic","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2019.108888_bib56","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.15252\/embj.201796697","article-title":"Molecular definitions of autophagy and related processes","volume":"36","author":"Galluzzi","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.cbi.2019.108888_bib57","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1182\/blood.V128.22.3950.3950","article-title":"Targeting autophagy as a therapeutic strategy in acute myeloid leukemia","volume":"128","author":"Nourkeyhani","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2019.108888_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.317","article-title":"Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia","author":"Folkerts","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2019.108888_bib59","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/15548627.2016.1278328","article-title":"Targeting AMPK-ULK1-mediated autophagy for combating BET inhibitor resistance in acute myeloid leukemia stem cells","volume":"13","author":"Jang","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.cbi.2019.108888_bib60","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2174\/15680096113139990088","article-title":"Autophagy in chronic myeloid leukemia: stem cell survival and implication in therapy","volume":"13","author":"Helgason","year":"2013","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.cbi.2019.108888_bib61","doi-asserted-by":"crossref","first-page":"96984","DOI":"10.18632\/oncotarget.18904","article-title":"Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence","volume":"8","author":"Ianniciello","year":"2017","journal-title":"Oncotarget"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719313821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719313821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:45:27Z","timestamp":1777387527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279719313821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":61,"alternative-id":["S0009279719313821"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2019.108888","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AMPK activation induced by promethazine increases NOXA expression and Beclin-1 phosphorylation and drives autophagy-associated apoptosis in chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2019.108888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108888"}}